{"id":"https://genegraph.clinicalgenome.org/r/57cf6c6e-7b98-47b7-a12a-cbeedf4f6c4ev1.1","type":"EvidenceStrengthAssertion","dc:description":"ADD3 is the γ-subunit of Adducin; a heterodimeric protein that provides structural support and maintains cytoskeletal interactions between actin and spectrin within neuronal structures. \n\nADD3 was first reported in relation to cerebral palsy, spastic quadriplegic, 3 in 2013 (Kruer et al., PMID:23836506). It is characterized by spastic quadriplegia/diplegia, cognitive impairment, speech impairment, strabismus, and borderline to true microcephaly in infancy. Other less common phenotypes include facial dysmorphisms, cataracts, and neuroimaging abnormalities; the latter including white matter hyperintensities, anomalies of the corpus callosum, and grey matter heterotopia. \nThe aforementioned disease entities have been grouped together as one disease entity: Complex neurodevelopmental disorder with motor features (MONDO: 0100516). \n\nEvidence supporting this gene-disease relationship includes case-level data and experimental data. Summary of Case Level Data: 6 POINTS. 5 unique missense variants that have been reported in 5 probands in 3 publications (PMID: 23836506, 30369941, 29768408) are included in this curation. This gene-disease association is also supported by a Drosophila model, where knockdown resulted in impaired locomotion, deficient climbing ability, and lesions in the brain lamina and medulla (PMID: 23836506). \n\nIn summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish a definitive relationship, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Cerebral Palsy Gene Curation Expert Panel on August 15, 2022 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/57cf6c6e-7b98-47b7-a12a-cbeedf4f6c4e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/8a858435-3e50-406f-8ec3-9f4e40b1c392","calculatedEvidenceStrength":"Moderate","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/8a858435-3e50-406f-8ec3-9f4e40b1c392_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":"2022-08-15T18:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/8a858435-3e50-406f-8ec3-9f4e40b1c392_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10113","date":"2022-12-27T21:05:19.652Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a858435-3e50-406f-8ec3-9f4e40b1c392_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a858435-3e50-406f-8ec3-9f4e40b1c392_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94f2cdf2-8910-439b-8ea7-f3effc07da2f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff04a55e-3c21-4e08-a4b0-2cbfa6b3b4cb","type":"Finding","dc:description":"Genomic variants in ADD3 have been reported in association with motor deficits (spastic diplegia/quadriplegia). Therefore, locomotion and climbing deficits in this drosophila model are in line with this phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23836506","rdfs:label":"Characterization of Adducin Loss of Function in Drosophila","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8a858435-3e50-406f-8ec3-9f4e40b1c392_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fcbbbba7-f015-40dd-9593-fac192363dc7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fcbbbba7-f015-40dd-9593-fac192363dc7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23836506","rdfs:label":"Sibling II-1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/90e2c12d-e076-43d6-8f45-122eba293540","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016824.5(ADD3):c.1100G>A (p.Gly367Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5686536"}},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"Spastic Quadriplegia (onset at 3 months)\nSevere Intellectual disability\nDysphagia\nSpeech impairment\nAbnormal brain MRI","previousTesting":true,"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5087b293-55fd-4ecb-862c-b49ee02d5b25_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23836506","allele":{"id":"https://genegraph.clinicalgenome.org/r/90e2c12d-e076-43d6-8f45-122eba293540"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/5087b293-55fd-4ecb-862c-b49ee02d5b25","type":"EvidenceLine","dc:description":"c.1100G>A is a recurrent variant","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5087b293-55fd-4ecb-862c-b49ee02d5b25_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5087b293-55fd-4ecb-862c-b49ee02d5b25_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional studies in patient fibroblasts found that the variant p. Gly367Asp impairs the normal actin-capping function of adducin, leading to both abnormal proliferation and migration in cultured patient fibroblasts.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/89807f42-20a9-4c1d-9501-7c15ccea2ce7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89807f42-20a9-4c1d-9501-7c15ccea2ce7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","rdfs:label":"Sibling II-6","allele":{"id":"https://genegraph.clinicalgenome.org/r/8b863f79-1b6c-4811-afdd-6b23dded2335","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016824.5(ADD3):c.1975G>C (p.Glu659Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5686787"}},"detectionMethod":"ES was performed for probands II-3 and II-6 from family A","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Intellectual disability\nBorderline microcephaly\nCongenital cataracts\nAbnormal brain MRI\nDysmorphic features\nArachnodactyly\nScoliosis\nDilated cardiomyopathy\nFocal segmental glomerulosclerosis","previousTesting":true,"previousTestingDescription":"Muscle biopsy and Karyotype were normal","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/033d8716-c4b8-4283-932e-013169e6b0ec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","allele":{"id":"https://genegraph.clinicalgenome.org/r/8b863f79-1b6c-4811-afdd-6b23dded2335"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/033d8716-c4b8-4283-932e-013169e6b0ec","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/033d8716-c4b8-4283-932e-013169e6b0ec_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/033d8716-c4b8-4283-932e-013169e6b0ec_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Gonçalves et al. (PMID:29768408) performed functional validation of this variant in Drosophila. Co-expression of adducin -γ E659Q together with wild type adducin-α resulted in a significantly reduced partial rescue of fly viability. The surviving animals showed climbing impairment in a geotaxis assay\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/edb7cb37-364a-4d3f-b06c-4007f4644dbf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/edb7cb37-364a-4d3f-b06c-4007f4644dbf","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","rdfs:label":"Sibling II-4","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a5e843a9-1630-4133-9d2f-360ea323e531","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016824.5(ADD3):c.86A>G (p.Asn29Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5686257"}},{"id":"https://genegraph.clinicalgenome.org/r/1a333be1-f6cf-4114-80c0-8bd7aaa10289","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016824.5(ADD3):c.1588G>A (p.Val530Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5686658"}}],"firstTestingMethod":"Exome sequencing","previousTesting":true,"previousTestingDescription":"Normal karyotype and normal CGH array","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/9faee8cf-f2ee-488e-a943-3143aed9e3ff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a333be1-f6cf-4114-80c0-8bd7aaa10289"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/051c45f4-e4c6-442b-8bc2-b82343fb34b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","allele":{"id":"https://genegraph.clinicalgenome.org/r/a5e843a9-1630-4133-9d2f-360ea323e531"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/051c45f4-e4c6-442b-8bc2-b82343fb34b9","type":"EvidenceLine","dc:description":"The proband is heterozygous for the ADD3 autosomal recessive variant c.995A>6 which is a recurrent variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/051c45f4-e4c6-442b-8bc2-b82343fb34b9_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/9faee8cf-f2ee-488e-a943-3143aed9e3ff","type":"EvidenceLine","dc:description":"The proband is heterozygous for the ADD3 autosomal recessive variant c.995A>6 which is a recurrent variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9faee8cf-f2ee-488e-a943-3143aed9e3ff_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/77ea4efc-7119-41e4-990a-5a51dbdaa96a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/77ea4efc-7119-41e4-990a-5a51dbdaa96a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","rdfs:label":"Sibling II-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/6c130528-3d9b-4320-a9ec-2b13e571bb78","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016824.5(ADD3):c.995A>G (p.Asn332Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5686514"}},"ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"\"Suspected\" Cerebral palsy\nMicrocephaly\nIntellectual disability\nEpilepsy\nFacial dysmorphism\nShort stature\n","previousTesting":true,"previousTestingDescription":"Karyotype, CGH array, and muscle biopsy were normal","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/aa9b9ad8-de2d-44a5-9cb5-2c982a5af18e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","allele":{"id":"https://genegraph.clinicalgenome.org/r/6c130528-3d9b-4320-a9ec-2b13e571bb78"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/aa9b9ad8-de2d-44a5-9cb5-2c982a5af18e","type":"EvidenceLine","dc:description":"p. Asn332Ser is a recurrent variant","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa9b9ad8-de2d-44a5-9cb5-2c982a5af18e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d8c62db4-9e86-4174-a659-09e2004cb8de_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8c62db4-9e86-4174-a659-09e2004cb8de","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30369941","rdfs:label":"Group 2, Consanguineous family, ADD3 proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/90e2c12d-e076-43d6-8f45-122eba293540"},"firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"Spastic quadriplegia\nIntellectual disability\nEpilepsy","previousTesting":false,"secondTestingMethod":"Exome sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/02cd473e-e45e-404c-972e-6073d273d3ee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30369941","allele":{"id":"https://genegraph.clinicalgenome.org/r/90e2c12d-e076-43d6-8f45-122eba293540"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/02cd473e-e45e-404c-972e-6073d273d3ee","type":"EvidenceLine","dc:description":"c. 1100G>A (p.Gly367Asp)","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02cd473e-e45e-404c-972e-6073d273d3ee_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/02cd473e-e45e-404c-972e-6073d273d3ee_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Kruer et al. (PMID:23836506) functional study of this variant revealed that it impairs the ability of gamma adducin to associate with the alpha subunit, impairing the actin-capping activity of adducin in mutant fibroblasts","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8a858435-3e50-406f-8ec3-9f4e40b1c392_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cbed682-a708-43af-a88c-068d9989bcd0_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23836506","rdfs:label":"Jordanian Family","family":{"id":"https://genegraph.clinicalgenome.org/r/2cbed682-a708-43af-a88c-068d9989bcd0","type":"Family","rdfs:label":"Jordanian Family","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fcbbbba7-f015-40dd-9593-fac192363dc7"}},"phenotypeFreeText":"Spastic diplegia/quadriplegia\nIntellectual disability\nStrabismus\nDysphagia\nSpeech impairment\nAbnormal brain MRI","phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/fcbbbba7-f015-40dd-9593-fac192363dc7"}},{"id":"https://genegraph.clinicalgenome.org/r/44e1137c-d9e6-4885-a01c-99b1d90d8c85_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","rdfs:label":"Family C ","family":{"id":"https://genegraph.clinicalgenome.org/r/44e1137c-d9e6-4885-a01c-99b1d90d8c85","type":"Family","rdfs:label":"Family C ","member":{"id":"https://genegraph.clinicalgenome.org/r/77ea4efc-7119-41e4-990a-5a51dbdaa96a"}},"phenotypeFreeText":"Microcephaly\nIntellectual disability\nEpilepsy","phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/77ea4efc-7119-41e4-990a-5a51dbdaa96a"}},{"id":"https://genegraph.clinicalgenome.org/r/22c15843-fd9d-42e6-a298-e16cf5bb33a2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","rdfs:label":"Family B","family":{"id":"https://genegraph.clinicalgenome.org/r/22c15843-fd9d-42e6-a298-e16cf5bb33a2","type":"Family","rdfs:label":"Family B","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/edb7cb37-364a-4d3f-b06c-4007f4644dbf"}},"phenotypeFreeText":"Intellectual disability\nCorpus callosum anomalies\nMicrocephaly\nFacial dysmorphism\nShort stature","phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/edb7cb37-364a-4d3f-b06c-4007f4644dbf"}},{"id":"https://genegraph.clinicalgenome.org/r/3000b56b-a9e7-4ccf-9a7d-b3b49cbbacd2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29768408","rdfs:label":"Family A","family":{"id":"https://genegraph.clinicalgenome.org/r/3000b56b-a9e7-4ccf-9a7d-b3b49cbbacd2","type":"Family","rdfs:label":"Family A","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/89807f42-20a9-4c1d-9501-7c15ccea2ce7"}},"phenotypeFreeText":"Intellectual disability\nBorderline microcephaly\nCongenital cataracts\nAbnormal brain MRI\nDysmorphic features\nArachnodactyly\nScoliosis\nDilated cardiomyopathy\nFocal segmental glomerulosclerosis","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/89807f42-20a9-4c1d-9501-7c15ccea2ce7"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Moderate","sequence":5583,"specifiedBy":"GeneValidityCriteria9","strengthScore":8,"subject":{"id":"https://genegraph.clinicalgenome.org/r/TWUeGvUNZi8","type":"GeneValidityProposition","disease":"obo:MONDO_0100516","gene":"hgnc:245","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_8a858435-3e50-406f-8ec3-9f4e40b1c392-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}